Armando Anido, Chairman & CEO at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 11,899 shares at $1.10 ($13K) on 2022-07-19, disclosed to the SEC on 2022-07-20.
Open-market sale of $13k ZYNE by Chairman & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SCYX | BUY | 2020-12-23 | $31K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $89K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $99K | — | Filing → |